Propofol versus thiopental sodium for the treatment of refractory status epilepticus
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Propofol Versus Thiopental Sodium for the Treatment of Refractory Status Epilepticus." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435816/2/Sargramostim__GM_CSF__for_induction_of_remission_in_Crohn's_disease:_Cochrane_systematic_review. Accessed 24 April 2024.
Propofol versus thiopental sodium for the treatment of refractory status epilepticus. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435816/2/Sargramostim__GM_CSF__for_induction_of_remission_in_Crohn's_disease:_Cochrane_systematic_review. Accessed April 24, 2024.
Propofol versus thiopental sodium for the treatment of refractory status epilepticus. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/435816/2/Sargramostim__GM_CSF__for_induction_of_remission_in_Crohn's_disease:_Cochrane_systematic_review
Propofol Versus Thiopental Sodium for the Treatment of Refractory Status Epilepticus [Internet]. In: Cochrane Abstracts. [cited 2024 April 24]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435816/2/Sargramostim__GM_CSF__for_induction_of_remission_in_Crohn's_disease:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Propofol versus thiopental sodium for the treatment of refractory status epilepticus
ID - 435816
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435816/2/Sargramostim__GM_CSF__for_induction_of_remission_in_Crohn's_disease:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -